NASDAQ · Financial Statements
DICE Therapeutics, Inc. (DICE) Financial Statements
$47.55
NASDAQ: DICE
Market Cap $2.27B
Overview Financials Dividend DICE Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-82.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 Revenue $6.0M $1.0M $1.0M $0 Operating Profit $-14.0M $-24.0M $-48.0M $-88.0M Net Profit $-13.0M $-24.0M $-48.0M $-82.0M EPS $-0.56 $-1.02 $-3.91 $-2.07 Op Margin -234.6% -2748.7% -4231.4% —
Balance Sheet (USD)
Metric 2019 2020 2021 2022 Total Assets $31.0M $64.0M $326.0M $594.0M Total Liabilities $61.0M $117.0M $13.0M $27.0M Cash $8.0M $60.0M $116.0M $461.0M Borrowings $0 $0 $2.0M $13.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 Operating Cash Flow $-16.0M $-21.0M $-39.0M $-64.0M Investing Cash Flow $-20.0M $18.0M $-205.0M $85.0M Financing Cash Flow $0 $54.0M $300.0M $322.0M Net Cash Flow $-36.0M $51.0M $56.0M $345.0M Free Cash Flow $-17.0M $-21.0M $-40.0M $-67.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.64 EV / EBITDA -21.96 FCF Yield -2.93% Quick Ratio 38.14 Interest Coverage -129.93 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock